Comment on ‘KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer'

por Tougeron, D, Laurent-Puig, P, Zaanan, A
Publicado 2014

Increased p53 protein content of colorectal tumours correlates with poor survival.

por Remvikos, Y., Tominaga, O., Hammel, P., Laurent-Puig, P., Salmon, R. J., Dutrillaux, B., Thomas, G.
Publicado 1992

Clinicopathological significance of mitochondrial D-Loop mutations in head and neck carcinoma

por Lièvre, A, Blons, H, Houllier, A M, Laccourreye, O, Brasnu, D, Beaune, P, Laurent-Puig, P
Publicado 2006

Sensitivity to CPT-11 of xenografted human colorectal cancers as a function of microsatellite instability and p53 status

por Bras-Gonçalves, R A, Rosty, C, Laurent-Puig, P, Soulié, P, Dutrillaux, B, Poupon, M-F
Publicado 2000

Expression of pEGFR and pAKT as response-predictive biomarkers for RAS wild-type patients to anti-EGFR monoclonal antibodies in metastatic colorectal cancers

por Harlé, A, Salleron, J, Perkins, G, Pilati, C, Blons, H, Laurent-Puig, P, Merlin, J L
Publicado 2015

Influence of epidermal growth factor receptor (EGFR), p53 and intrinsic MAP kinase pathway status of tumour cells on the antiproliferative effect of ZD1839 (‘Iressa’)

por Magné, N, Fischel, J L, Dubreuil, A, Formento, P, Poupon, M-F, Laurent-Puig, P, Milano, G
Publicado 2002

An architecture for genomics analysis in a clinical setting using Galaxy and Docker

por Digan, W, Countouris, H, Barritault, M, Baudoin, D, Laurent-Puig, P, Blons, H, Burgun, A, Rance, B
Publicado 2017

Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity

por Etienne, M-C, Ilc, K, Formento, J-L, Laurent-Puig, P, Formento, P, Cheradame, S, Fischel, J-L, Milano, G
Publicado 2004

Microsatellite instability and intratumoural heterogeneity in 100 right-sided sporadic colon carcinomas

por Chapusot, C, Martin, L, Bouvier, A M, Bonithon-Kopp, C, Ecarnot-Laubriet, A, Rageot, D, Ponnelle, T, Laurent Puig, P, Faivre, J, Piard, F
Publicado 2002

UDP-glucuronosyltransferase UGT1A7 genetic polymorphisms in hepatocellular carcinoma: a differential impact according to seropositivity of HBV or HCV markers?

por Stücker, I, Loriot, MA, N'Koutchou, G, Cénée, S, Bodin, L, Mulot, C, Gelu-Simeon, M, Pelletier, L, Bronowicki, JP, Degos, F, Beaune, P, Laurent-Puig, P, Hémon, D, Trinchet, JC, Pelletier, G
Publicado 2007

Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study

por Aparicio, T, Svrcek, M, Zaanan, A, Beohou, E, Laforest, A, Afchain, P, Mitry, Emmanuel, Taieb, J, Di Fiore, F, Gornet, J-M, Thirot-Bidault, A, Sobhani, I, Malka, D, Lecomte, T, Locher, C, Bonnetain, F, Laurent-Puig, P
Publicado 2013

Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial

por Samalin, E, Bouché, O, Thézenas, S, Francois, E, Adenis, A, Bennouna, J, Taieb, J, Desseigne, F, Seitz, J F, Conroy, T, Galais, M P, Assenat, E, Crapez, E, Poujol, S, Bibeau, F, Boissière, F, Laurent-Puig, P, Ychou, M, Mazard, T
Publicado 2014

Meeting report from the joint IARC–NCI international cancer seminar series: a focus on colorectal cancer

por Gunter, M J, Alhomoud, S, Arnold, M, Brenner, H, Burn, J, Casey, G, Chan, A T, Cross, A J, Giovannucci, E, Hoover, R, Houlston, R, Jenkins, M, Laurent-Puig, P, Peters, U, Ransohoff, D, Riboli, E, Sinha, R, Stadler, Z K, Brennan, P, Chanock, S J
Publicado 2019

Molecular patterns in deficient mismatch repair colorectal tumours: results from a French prospective multicentric biological and genetic study

por Etienne-Grimaldi, M-C, Mahamat, A, Chazal, M, Laurent-Puig, P, Olschwang, S, Gaub, M-P, Formento, J-L, Formento, P, Sudaka, A, Boige, V, Abderrahim-Ferkoune, A, Benchimol, D, André, T, Houry, S, Faucheron, J-L, Letoublon, C, Gilly, F-N, Delpero, J-R, Lasser, P, Pradere, B, Pezet, D, Penault-Llorca, F, Milano, G
Publicado 2014

The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022

por Ducreux, M., Abou-Alfa, G.K., Bekaii-Saab, T., Berlin, J., Cervantes, A., de Baere, T., Eng, C., Galle, P., Gill, S., Gruenberger, T., Haustermans, K., Lamarca, A., Laurent-Puig, P., Llovet, J.M., Lordick, F., Macarulla, T., Mukherji, D., Muro, K., Obermannova, R., O’Connor, J.-M., O’Reilly, E.M., Osterlund, P., Philip, P., Prager, G., Ruiz-Garcia, E., Sangro, B., Seufferlein, T., Tabernero, J., Verslype, C., Wasan, H., Van Cutsem, E.
Publicado 2023

Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study

por Andreyev, H J N, Norman, A R, Cunningham, D, Oates, J, Dix, B R, Iacopetta, B J, Young, J, Walsh, T, Ward, R, Hawkins, N, Beranek, M, Jandik, P, Benamouzig, R, Jullian, E, Laurent-Puig, P, Olschwang, S, Muller, O, Hoffmann, I, Rabes, H M, Zietz, C, Troungos, C, Valavanis, C, Yuen, S T, Ho, J W C, Croke, C T, O'Donoghue, D P, Giaretti, W, Rapallo, A, Russo, A, Bazan, V, Tanaka, M, Omura, K, Azuma, T, Ohkusa, T, Fujimori, T, Ono, Y, Pauly, M, Faber, C, Glaesener, R, Goeij, A F P M de, Arends, J W, Andersen, S N, Lövig, T, Breivik, J, Gaudernack, G, Clausen, O P F, Angelis, P De, Meling, G I, Rognum, T O, Smith, R, Goh, H-S, Font, A, Rosell, R, Sun, X F, Zhang, H, Benhattar, J, Losi, L, Lee, J Q, Wang, S T, Clarke, P A, Bell, S, Quirke, P, Bubb, V J, Piris, J, Cruickshank, N R, Morton, D, Fox, J C, Al-Mulla, F, Lees, N, Hall, C N, Snary, D, Wilkinson, K, Dillon, D, Costa, J, Pricolo, V E, Finkelstein, S D, Thebo, J S, Senagore, A J, Halter, S A, Wadler, S, Malik, S, Krtolica, K, Urosevic, N
Publicado 2001